Drug Trial Radar · NCT03600441
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Last checked: Nov 19, 2026Latest source record: Apr 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
139
Planned (sponsor's estimate)
Start
Aug 27, 2018
Primary completion
Dec 31, 2027
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Xynomic Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study in patients with relapsed/refractory follicular lymphoma who have undergone at least 3 lines of therapy. Patients will receive abexinostat 80 mg (4 × 20 mg tablets) twice a day (BID) in a "one week on, one week off" schedule.
Conditions
- Follicular Lymphoma
Interventions
AbexinostatDrug
Abexinostat tosylate salt is formulated into an oral tablet formulation and is available in 20 mg strength.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical effect of abexinostatTime frame: Time frame up to 100 months
Locations
15 sites in 3 countries. Site status is shown where the registry gives one.
Advocate Medical Group - Park Ridge, Luther Lane - Oncology
Park Ridge, Illinois
Norton Cancer Institute - St. Matthews Campus
Louisville, Kentucky
Clinical Research Alliance Inc
Lake Success, New York
Manhattan Hematology Oncology Center
New York, New York
Memorial Sloan Kettering Cancer Center
New York, New York
Bone Marrow Transplant Hematology Oncology Associates
Pittsburgh, Pennsylvania
Arlington Cancer Center
Arlington, Texas
Central Texas Veterans Health Care System - NAVREF
Temple, Texas
Vista Oncology Inc. PS
Olympia, Washington
Centre Hospitalier de Perpignan
Perpignan, Pyrénées-Orientales, France
Hospital Universitario Vall d'Hebrón
Barcelona, Spain
Hospital del Mar
Barcelona, Spain
C.H. Regional Reina Sofia
Córdoba, Spain
Hospital Universitario Infanta Leonor
Madrid, Spain
Hospital Universitario de Donostia
Donostia / San Sebastian, Guipúzcoa, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.